Conjunctivitis, Bacterial Completed Phase 2 Trials for Besifloxacin (DB06771)

Also known as: Bacterial Conjunctivitis / Pink eye disease / Purulent conjunctivitis / Mucopurulent conjunctivitis / Conjunctivitis bacterial NOS / Conjunctivitis bacterial

IndicationStatusPhase
DBCOND0035308 (Conjunctivitis, Bacterial)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00622908Clinical and Microbial Efficacy of ISV403 in Bacterial ConjunctivitisTreatment